PubMed, Zhuge, Xiang-Lin, et al
In this review, we introduce advances in immune microenvironment-driven immunotherapies for HCC, describe varieties of aberrant lipid metabolism in the liver that guide the application of statin as a cholesterol-lowering agent in HCC treatment, and discuss the potential use of stain in future immune therapy strategies for combinational treatment, based on observations mostly from long-term population studies and clinical trials
Neutralization of oxidation radicals becomes paramount in SARS-CoV-2-mediated cellular and tissue damage
For many people, these options can be effective and more accessible while newer medications like retatrutide are still being studied
Melatonin supplementation attenuates cuproptosis and ferroptosis in aging cumulus and granulosa cells: potential for improving IVF outcomes in advanced maternal age
Determination That GEREF (Sermorelin Acetate) Injection Were Not Withdrawn for Reasons of Safety or Effectiveness